{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:29:57Z","timestamp":1790566197218,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>CDX2 expression loss is commonly associated with mismatch repair deficiency (dMMR) in colorectal cancer (CRC). However, there are only a few studies that have attempted to correlate CDX2 expression loss with specific MMR genes (<jats:italic>MLH1<\/jats:italic>, <jats:italic>MSH2<\/jats:italic>, <jats:italic>MSH6<\/jats:italic>, <jats:italic>PMS2<\/jats:italic>). This is a retrospective study of 327 patients who underwent surgery due to CRC. Nine patients (2.9%) had two synchronous CRCs, making the total sample 336 CRC. Histopathological data such as tumor type, tumor grade, perineural, lymphatic, and vascular invasion, pT stage, pN stage, peritumoral and intratumoral lymphocytic infiltration were collected and recorded in the database. After immunohistochemical analysis, CDX2 expression, MLH1, MSH2, MSH6, and PMS2 deficiency were also recorded. CDX2 expression loss was detected in 19 out of 336 CRCs (5.9%) and was associated with ascending colon CRC, partially mucinous adenocarcinoma, poorly differentiated carcinoma, and dMMR. Forty-four (13.1%) of CRCs were dMMR. We found a statistically significant association between CDX2 expression loss and MLH1 and PMS2 deficiency. Considering that most expression phenotypes include pairs of MMR genes, we analyzed MLH1\/PMS2 and MSH2\/MSH6 as heterodimers. Analysis of heterodimers showed a similar result, namely, that MLH1\/PMS2 heterodimer deficiency was significantly associated with CDX2 expression loss. We also constructed a regression model for CDX2 expression loss and for dMMR. Poor tumor differentiation and MLH1\/PMS2 heterodimer deficiency have been identified as potential predictors for CDX2 expression loss. CRC in the ascending colon and CDX2 expression loss have been identified as positive potential predictors of dMMR with rectal cancer as negative potential predictor of dMMR. Our study showed a significant association between CDX2 expression loss and MLH1 and PMS2 deficiency in CRC. We also managed to produce a regression model for CDX2 expression and showed that poor tumor differentiation and MLH1\/PMS2 heterodimer deficiency are independent factors for CDX2 expression loss. We were the first to include CDX2 expression in a regression model for dMMR and showed that CDX2 expression loss can be used as a predictive factor for dMMR, which should be confirmed by further studies.<\/jats:p>","DOI":"10.3389\/pore.2023.1610908","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T14:57:25Z","timestamp":1685545045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer"],"prefix":"10.3389","volume":"29","author":[{"given":"Ivan","family":"Vlahovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Rajc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"\u0160vagelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kre\u0161imir","family":"\u0160oli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dra\u017een","family":"\u0160vagelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4240\/wjgs.v3.i11.159","article-title":"CDX2 as a marker for intestinal differentiation: Its utility and limitations","volume":"3","author":"Saad","year":"2011","journal-title":"World J Gastrointest Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s12029-019-00314-w","article-title":"CDX2 protein expression in colorectal cancer and ItsCorrelation with clinical and pathological characteristics, prognosis, and survival rate of patients","volume":"51","author":"Asgari-Karchekani","year":"2020","journal-title":"J Gastrointest Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yexmp.2015.11.009","article-title":"CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer","volume":"100","author":"Olsen","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fonc.2013.00265","article-title":"Loss of Cdx2 expression in primary tumors and lymph node metastases is specific for mismatch repair-deficiency in colorectal cancer","volume":"3","author":"Dawson","year":"2013","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3748\/wjg.v21.i5.1457","article-title":"Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients","volume":"21","author":"Bae","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1506597","article-title":"CDX2 as a prognostic biomarker in stage II and stage III colon cancer","volume":"374","author":"Dalerba","year":"2016","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jval.2021.07.019","article-title":"CDX2 biomarker testing and adjuvant therapy for stage II colon cancer: An exploratory cost-effectiveness analysis","volume":"25","author":"Alarid-Escudero","year":"2022","journal-title":"Value Heal"},{"key":"B9","volume-title":"TNM classification of malignant tumours","author":"Brierly","year":"2017"},{"key":"B10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41379-020-0634-9","article-title":"Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II\u2013III colon cancer","volume":"34","author":"Hestetun","year":"2021","journal-title":"Mod Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12957-017-1158-8","article-title":"Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters","volume":"15","author":"Hashmi","year":"2017","journal-title":"World J Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00428-018-2360-y","article-title":"The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer","volume":"473","author":"Neumann","year":"2018","journal-title":"Virchows Arch"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41416-021-01553-0","article-title":"Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin\u2013eosin-based morphologic parameters from the WHO classification","volume":"125","author":"Konukiewitz","year":"2021","journal-title":"Br J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/PAS.0b013e31829ab1c1","article-title":"Loss of CDX2\/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer","volume":"37","author":"Kim","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/1878-0261.12347","article-title":"Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer","volume":"12","author":"Bruun","year":"2018","journal-title":"Mol Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1158\/1078-0432.CCR-09-0401","article-title":"Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer","volume":"15","author":"Baba","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12885-021-08070-6","article-title":"Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients","volume":"21","author":"Ribeirinho-Soares","year":"2021","journal-title":"BMC Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17056","DOI":"10.18632\/oncotarget.24842","article-title":"CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: A single-center retrospective study in Japan","volume":"9","author":"Shigematsu","year":"2018","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdx066","article-title":"CDX2 prognostic value in stage II\/III resected colon cancer is related to CMS classification","volume":"28","author":"Pilati","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1186\/s12885-018-4902-8","article-title":"Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis","volume":"18","author":"Shigematsu","year":"2018","journal-title":"BMC Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/PAS.0000000000001356","article-title":"CDX2 loss with microsatellite stable phenotype predicts poor clinical outcome in stage II colorectal carcinoma","volume":"43","author":"Slik","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13148-018-0548-2","article-title":"CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway","volume":"10","author":"Graule","year":"2018","journal-title":"Clin Epigenetics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.47162\/RJME.61.3.10","article-title":"Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: Molecular characteristics and impact on prognosis and survival - an immunohistochemical study","volume":"61","author":"Melincovici","year":"2020","journal-title":"Rom J Morphol Embryol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1158\/0008-5472.CAN-04-3645","article-title":"CDX2 polymorphisms, RNA expression, and risk of colorectal cancer","volume":"65","author":"Rozek","year":"2005","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1002\/cam4.4810","article-title":"Transcriptome of sessile serrated adenoma\/polyps is associated with MSI- high colorectal cancer and decreased expression of CDX2","author":"Ohki","year":"2022","journal-title":"Cancer Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/bjs5.91","article-title":"Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer","volume":"2","author":"Ryan","year":"2018","journal-title":"BJS Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/modpathol.2008.117","article-title":"Differential diagnostic and functional role of the multi-marker phenotype CDX2\/CK20\/CK7 in colorectal cancer stratified by mismatch repair status","volume":"21","author":"Lugli","year":"2008","journal-title":"Mod Pathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/ijc.28564","article-title":"Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency","volume":"134","author":"Dawson","year":"2014","journal-title":"Int J Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clcc.2018.02.001","article-title":"Association of CDX2 expression with survival in early colorectal cancer: A systematic review and meta-analysis","volume":"17","author":"Tomasello","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.23750\/abm.v89i9-S.7960","article-title":"Microsatellite instability in colorectal cancer","volume":"89","author":"De\u2019angelis","year":"2018","journal-title":"Acta Biomed"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5114\/pjp.2015.54958","article-title":"Relationship among mismatch repair deficiency, CDX2 loss, p53 and E-cadherin in colon carcinoma and suitability of using a double panel of mismatch repair proteins by immunohistochemistry","volume":"66","author":"Sayar","year":"2015","journal-title":"Polish J Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.3892\/ol.2018.7756","article-title":"Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer","volume":"15","author":"T\u00f3th","year":"2018","journal-title":"Oncol Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.3748\/wjg.v20.i15.4230","article-title":"Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e6224","DOI":"10.1097\/MD.0000000000006224","article-title":"Clinicopathological features and surgical options for synchronous colorectal cancer","volume":"96","author":"Lee","year":"2017","journal-title":"Med (United States)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.21873\/anticanres.14441","article-title":"A model for Predicting DNA mismatch repair-deficient colorectal cancer","volume":"40","author":"Chikatani","year":"2020","journal-title":"Anticancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","article-title":"Pathology features in bethesda guidelines predict colorectal cancer microsatellite instability: A population-based study","volume":"133","author":"Jenkins","year":"2007","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/cam4.1088","article-title":"Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age","volume":"6","author":"Fujiyoshi","year":"2017","journal-title":"Cancer Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00428-010-0896-6","article-title":"Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model","volume":"456","author":"Rom\u00e1n","year":"2010","journal-title":"Virchows Arch"},{"key":"B41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/PAS.0b013e31817ec2b1","article-title":"Pathologic predictors of microsatellite instability in colorectal cancer","volume":"33","author":"Greenson","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2023.1610908\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T14:57:30Z","timestamp":1685545050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2023.1610908\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":41,"alternative-id":["10.3389\/pore.2023.1610908"],"URL":"https:\/\/doi.org\/10.3389\/pore.2023.1610908","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"article-number":"1610908"}}